Theracurmin™ is a nanosized curcumin formula made from a mixture of micronized curcumin and gum ghatti solution. Theracurmin’s particle size is reduced via a wet mill grinding process and then dispersed using a high-pressure blending technique. This creates a colloidal suspension that is highly water soluble. BCM-95® is a patented curcumin formula that combines curcumin and volatile agents in turmeric essential oil to increase bioavailability. The formula is also comprised of lecithin and medium chain triglycerides to further assist in this process. Turmeric essential oil constitutes approximately 9% of the formulation. Meriva® uses micelle technology to create a patented Phytosome®
MONACOLIN K-FREE RED YEAST RICE
Dr. Tzu-Ming Pan is an Emeritus Professor of Biotechnology at the National Taiwan University in Taipei. His research over many years focused on beneficial molecules produced by Monascus and many other plants and bacteria. His lab identified a strain of Monascus that did not make monacolin K, yet surprisingly was able to reduce LDL cholesterol in animal models.
After several years of work, Dr. Pan and his group isolated two molecules from red yeast rice that were responsible for this
Dr. Pan’s group and others have published almost 100 research papers in the last 10 years that reported these findings. The red yeast rice extract they produced was called Ankascin 568-R. It is enriched with
This data led to the inclusion of Ankascin in the FDA’s list of New Dietary Ingredients that are reasonably expected to be safe. It also received approval for sale by Health Canada’s Natural and Non-Prescription Health Products Directorate. As a supplement that is free of both monacolin K and citrinin, it is safe and effective for both short and long term use.
NOT ONLY COULD MONASCIN AND ANKAFLAVIN LOWER LDL CHOLESTEROL LEVELS IN THE BLOOD, THEY ALSO HELPED IN THE MANAGEMENT OF BLOOD PRESSURE, BLOOD SUGAR, AND ALZHEIMER’S DISEASE.